An edition of Use of single strand conformational polymorphism to delineate the potential link between Mullerian inhibiting substance and early onset ovarian cancer (1994)

Use of single strand conformational polymorphism to delineate the potential link between Mullerian inhibiting substance and early onset ovarian cancer

By Betty Tung Lee,Harvard University--MIT Division of Health Sciences and Technology